People · Operator
Named in public records as an officer, director or promoter · active 2013–2013 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Bell Biosystems, Inc. | — | Biotechnology | Seed | $6.2M | $169.2M | 2013 |
Bell, III B. Caleb at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Bell, III B. Caleb on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Daniel B. Bell | 1 | 1 |
| Bell B. Caleb | 1 | 1 |
| Stuart B. Berman | 1 | 1 |
| Caleb B. Bell | 1 | 1 |
| Una B. Ryan | 1 | 1 |
| Christian B. Olgaard | 1 | 1 |
| Gil B. Van Bokkelen | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.